NEW YORK (GenomeWeb News) – Life Technologies said today that it has agreed to buy the genomics technologies firm BioTrove for an undisclosed sum.

The definitive merger agreement will give Life Technologies a high-throughput gene expression and genotyping system, the OpenArray, that will complement the company’s next-generation and PCR portfolio by enabling researchers to validate samples against large target panels, Life Technologies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.